Search results
Agios (AGIO) Up 21% on Upbeat Data From 2nd Thalassemia Study
Zacks via Yahoo News· 1 month agoData from a late-stage study shows that transfusion-dependent thalassemia patients who received...
Biotech Stock Roundup: IRON, VERV Down on Study Updates, BMYs Drug News & More
Zacks via Yahoo News· 3 months agoPipeline and regulatory updates continue to be in focus in the biotech sector. While nothing much...
Shannyn Sossamon Likes To Disappear
HuffPost via Yahoo News· 1 month agoAhead of a new role in the movie “Backspot,” the actor reflects on Instagram, staying out of the limelight, and her own sporadic, sprawling career.
Weight-loss medications may help. They also may hurt. Here's what you need to know.
Yahoo Life· 11 months agoSemaglutide can help — but it can also hurt. (Photo illustration: Yahoo News; photos: Getty Images)...
Disc Medicine (IRON) Down on Mixed Results From AURORA Study
Zacks via Yahoo News· 3 months agoDisc Medicine's (IRON) shares lose after a phase II study of bitopertin in patients with...
Eli Lilly (LLY) Stock Up 18.7% YTD, New Drugs Key to Growth
Zacks via Yahoo News· 1 year agoLilly (LLY) expects to launch four new medicines by 2023 end, of which Mounjaro for type II diabetes...
Biogen (BIIB), Eisai Seek Full Nod for Alzheimer Drug Leqembi
Zacks via Yahoo News· 1 year agoThe FDA grants priority review to Biogen (BIIB) and Eisai's sBLA seeking traditional approval of...
Lilly's (LLY) Donanemab Slows Alzheimer's Disease Progression
Zacks via Yahoo News· 12 months agoData from a phase III study shows that treatment with Eli Lilly's (LLY) donanemab slowed cognitive...
The Most Exciting New Advances in Managing COPD
Time via Yahoo News· 4 months agoCredit - Karl Tapales—Getty Images The Global Initiative for Chronic Obstructive Lung Disease, or GOLD, is the world’s preeminent COPD research and...
Palisade Bio's (PALI) LB1148 Gets FDA Fast-Track Designation
Zacks via Yahoo News· 2 years agoPalisade Bio (PALI) gets Fast Track status from the FDA for its lead drug, LB1148, for accelerated...
